OpenAlex
PricingAboutJobs
Log inGet started
Work

Genetic Insights for Drug Development in NAFLD

HTML

Year: 2019
Type: review
Source: Trends in Pharmacological Sciences
DOI: 10.1016/j.tips.2019.05.002
Authors: Mohammed Eslam, Jacob George
Institutions: The University of Sydney, Westmead Hospital, Westmead Institute for Medical Research
Language: English

Topic: Liver Disease Diagnosis and Treatment
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: non-alcoholic fatty liver disease, drug development, drug target prioritization, genetic architecture, pharmacogenomics, drug discovery, pharmacotherapy
SDG: Good health and well-being

Open Access status: closed

Funder: National Health and Medical Research Council
Awards: G5537791738, MERTK receptor tyrosine kinase: A novel therapeutic target for liver fibrosis, Hepatitis C infection and disease, How does dietary cholesterol induce non-alcoholic steatohepatitis?
OpenAlex ID: W2947257201
FWCI: 1.197
Cites: 106
Cited by: 71
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security